pharma manufacturing news
McLaren alliance to turbocharge GSK research
September 16, 2011Manufacturing and Production, Research and Development GSK, manufacturing and production news, pharma manufacturing news, research and development news
GlaxoSmithKline has turned to the engineering expertise of Formula 1 racing team McLaren in an innovative alliance designed to transform …
Genzyme confirms further Fabrazyme delay
September 13, 2011Manufacturing and Production Fabrazyme, Genzyme, pharma manufacturing news
Genzyme has been forced to delay shipments of its Fabry disease treatment Fabrazyme once again, blaming its “quality release process”. …
Slow Provenge growth prompts Dendreon staff cull
September 13, 2011Business Services, Manufacturing and Production Dendreon, Provenge, job cuts, pharma manufacturing news
After months of building manufacturing capacity, US biotech Dendreon has decided to slash a quarter of its workforce – with …
Aurobindo forms Russian joint venture with Diod
September 13, 2011Manufacturing and Production, Sales and Marketing Aurobindo, Diod, pharma manufacturing news
Indian drugmaker Aurobindo has formed a joint venture with Russia’s OJSC Diod in order to tap into the local market …
Offshoring pharma manufacturing increases risk, says study
September 12, 2011Manufacturing and Production Puerto Rico, contract manufacturing, pharma manufacturing news
Drugs produced in offshore manufacturing plants – even those run by US manufacturers – pose a greater quality risk than …
Pharma manufacturing news in brief
September 12, 2011Manufacturing and Production pharma manufacturing news
DMV-Fonterra agrees to buy India’s Brahmar Cellulose, plus there are facility updates from Reliable and Toyoba, some bad press for …
Dendreon drops GSK as Provenge manufacturing partner
September 8, 2011Manufacturing and Production Dendreon, GSK, Provenge, pharma manufacturing news
Dendreon has called a halt to its manufacturing and supply deal with GlaxoSmithKline for cancer vaccine Provenge, citing “delays and …
New API production process ‘could transform pharma’
September 6, 2011Manufacturing and Production pharma manufacturing news, pharma production
UK researchers have started work on a new project to examine a new production method that they claim could “significantly …
CSL vaccine probe likely to rule out manufacturing errors
September 6, 2011Manufacturing and Production CSL Biotherapies, flu, pharma manufacturing news, vaccines
CSL Biotherapies has said that manufacturing errors were likely not to blame for febrile seizures in children who received its …
Pharma manufacturing news in brief
September 6, 2011Manufacturing and Production pharma manufacturing news
USP expands operations in India, DSM gets green light for Chinese anti-infective joint venture, plus there are updates from CMC …
Generic user fees could boost FDA inspection powers
August 22, 2011Manufacturing and Production Mylan, generics, pharma manufacturing news
Generic drugmakers have forged a tentative deal with the US government that could see user fees being used to help …
Pharma manufacturing news in brief
August 19, 2011Manufacturing and Production pharma manufacturing news
Lonza launches a stripped down material supply service for biologics developers, plus facility news from United Therapeutics, Dr Reddy’s and …
Onyx Scientific bought by India’s Ipca Labs
August 16, 2011Manufacturing and Production, Research and Development Ipca, Onyx, contract research news, pharma manufacturing news, research and development news
India’s Ipca Laboratories has bought UK chemistry services firm Onyx Scientific for around £4.6 million ($7.5m). The Mumbai-based company, a …
Contract manufacturing market set for return to growth
August 16, 2011Manufacturing and Production contract manufacturing, pharma manufacturing news
The pharmaceutical contract manufacturing sector looks set for a return to historical growth over the next five years, after a …
Pharma manufacturing news in brief
August 16, 2011Manufacturing and Production pharma manufacturing news
Jubilant announces an $80 million agreement to supply an unnamed product over the next three years, plus there are facility …
